drugset / Trial / NCT00648726
An Open, Prospective, Randomized, Multicenter Study of the Efficacy and Safety of Intravenous Followed by Oral Azithromycin Versus Cefuroxime Alone or With Oral Erythromycin for the Treatment of Chinese Patients Who Were Hospitalized for Pneumonia
RandomizedParallel-groupOpen-labelTreatment
Summary
To validate the efficacy and safety of azithromycin for the treatment of Chinese patients hospitalized with community-acquired pneumonia (CAP), compared with cefuroxime or the combination of cefuroxime plus oral erythromycin.
Timeline
- Start
- 2003-01
- Primary completion
- —
- Completion
- 2003-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Azithromycin | Small molecule | 500 mg | Intravenous |
| Comparator | Cefuroxime | Small molecule | 0.5 g | Intravenous |
| Comparator | Erythromycin | Small molecule | 0.5 g | Oral |